Kalderos, a Chicago, IL-based provider of a platform that delivers visibility into prescription drug discount compliance, raised $7m in Series A funding.
The round was funded by Mercato Partners.
The company intends to use the funds to accelerate market adoption of its platform.
Led by Jeremy Docken, CEO and co-founder, Kalderos is advancing a real-time, compliant, point-of-sale chargeback solution for the prescription drug market, which combines industry expertise, artificial intelligence, and deep-data libraries to ensure the right discounts are applied to the right transaction.
The company released its SaaS platform that detects problems in the complex financial interplay between pharmacies, insurers, manufacturers and payers in 2016. Current customers include seven of the 15 largest drug manufacturers.